Review





Similar Products

bl2081  (TissueArray.com LLC)
90
TissueArray.com LLC bl2081
Bl2081, supplied by TissueArray.com LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bl2081/product/TissueArray.com LLC
Average 90 stars, based on 1 article reviews
bl2081 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
bladder tumor tissue arrays bl2081  (U.S Biomax Inc)
90
U.S Biomax Inc bladder tumor tissue arrays bl2081
Bladder Tumor Tissue Arrays Bl2081, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bladder tumor tissue arrays bl2081/product/U.S Biomax Inc
Average 90 stars, based on 1 article reviews
bladder tumor tissue arrays bl2081 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
tma bl2081  (Biomax Inc)
90
Biomax Inc tma bl2081
EGFR and HER2 expression in bladder cancer. ( A ) TCGA dataset was used to show increased expression of EGFR and HER2 in bladder cancer. (i) EGFR is significantly elevated in bladder cancer compared to normal urothelium ( P < 0.01; ANOVA), specifically in ‘basal’ subtype classes 3 and 4. (ii) HER2 is significantly elevated in bladder cancer compared to the normal urothelium ( P < 0.01; ANOVA), specifically in ‘luminal’ subtype classes 1 and 2. ( B ) Tissue microarrays <t>BL2081</t> and BL806 (Biomax) were analyzed for the presence of EGFR and HER2 expression. 232 BC samples were stained, and 186 (80%) samples showed presence of either EGFR, HER2, or both. Of those, 79 (42.4%) samples and 23 (12.4%) showed only EGFR expression and only HER2 expression, respectively. 84 (45.2%) samples showed co-expression of EGFR and HER2.
Tma Bl2081, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tma bl2081/product/Biomax Inc
Average 90 stars, based on 1 article reviews
tma bl2081 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
tissue microarrays bl2081  (Biomax Inc)
90
Biomax Inc tissue microarrays bl2081
A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays <t>BL2081</t> and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.
Tissue Microarrays Bl2081, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tissue microarrays bl2081/product/Biomax Inc
Average 90 stars, based on 1 article reviews
tissue microarrays bl2081 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
tissue array blocks bl2081  (Biomax Inc)
90
Biomax Inc tissue array blocks bl2081
A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays <t>BL2081</t> and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.
Tissue Array Blocks Bl2081, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tissue array blocks bl2081/product/Biomax Inc
Average 90 stars, based on 1 article reviews
tissue array blocks bl2081 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
buc tissue microarray bl2081  (Biomax Inc)
90
Biomax Inc buc tissue microarray bl2081
A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays <t>BL2081</t> and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.
Buc Tissue Microarray Bl2081, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/buc tissue microarray bl2081/product/Biomax Inc
Average 90 stars, based on 1 article reviews
buc tissue microarray bl2081 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


EGFR and HER2 expression in bladder cancer. ( A ) TCGA dataset was used to show increased expression of EGFR and HER2 in bladder cancer. (i) EGFR is significantly elevated in bladder cancer compared to normal urothelium ( P < 0.01; ANOVA), specifically in ‘basal’ subtype classes 3 and 4. (ii) HER2 is significantly elevated in bladder cancer compared to the normal urothelium ( P < 0.01; ANOVA), specifically in ‘luminal’ subtype classes 1 and 2. ( B ) Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for the presence of EGFR and HER2 expression. 232 BC samples were stained, and 186 (80%) samples showed presence of either EGFR, HER2, or both. Of those, 79 (42.4%) samples and 23 (12.4%) showed only EGFR expression and only HER2 expression, respectively. 84 (45.2%) samples showed co-expression of EGFR and HER2.

Journal: Scientific Reports

Article Title: Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)

doi: 10.1038/s41598-019-38575-x

Figure Lengend Snippet: EGFR and HER2 expression in bladder cancer. ( A ) TCGA dataset was used to show increased expression of EGFR and HER2 in bladder cancer. (i) EGFR is significantly elevated in bladder cancer compared to normal urothelium ( P < 0.01; ANOVA), specifically in ‘basal’ subtype classes 3 and 4. (ii) HER2 is significantly elevated in bladder cancer compared to the normal urothelium ( P < 0.01; ANOVA), specifically in ‘luminal’ subtype classes 1 and 2. ( B ) Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for the presence of EGFR and HER2 expression. 232 BC samples were stained, and 186 (80%) samples showed presence of either EGFR, HER2, or both. Of those, 79 (42.4%) samples and 23 (12.4%) showed only EGFR expression and only HER2 expression, respectively. 84 (45.2%) samples showed co-expression of EGFR and HER2.

Article Snippet: Two commercially available TMAs were purchased from Biomax (Rockville, MD): BL2081 and BL806.

Techniques: Expressing, Staining

A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.

Journal: Molecular cancer therapeutics

Article Title: Epidermal Growth Factor Receptor (EGFR) Targeted Photoimmunotherapy (PIT) for the Treatment of EGFR expressing Bladder Cancer

doi: 10.1158/1535-7163.MCT-16-0924

Figure Lengend Snippet: A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.

Article Snippet: Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267).

Techniques: Staining, Expressing

A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.

Journal: Molecular cancer therapeutics

Article Title: Epidermal Growth Factor Receptor (EGFR) Targeted Photoimmunotherapy (PIT) for the Treatment of EGFR expressing Bladder Cancer

doi: 10.1158/1535-7163.MCT-16-0924

Figure Lengend Snippet: A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.

Article Snippet: Commercially available tissue array blocks BL2081 and BL 806 (Biomax, Rockville, MD) were similarly stained with anti-EGFR antibody to detect the expression of EGFR in bladder tumors of various stages, grades, and histologies as well as adjacent normal bladder tissues.

Techniques: Staining, Expressing